Nutriband stock analysis
Nutriband (9WV) Stock Price & Analysis
9WV Stock Chart & Stats
- Day’s Range
- EUR 4.68 - EUR 4.92
- 52-Week Range
- EUR 2.12 - EUR 8.20
- Previous Close
- EUR 4.70
- Volume
- N/A
- Average Volume (3M)
- 11
- Market Cap
- EUR 60.11M
- Enterprise Value
- EUR 59.94M
- Total Cash (Recent Filing)
- EUR 3.42M
- Total Debt (Recent Filing)
- EUR 194.62K
- Price to Earnings (P/E)
- ―
- Beta
- 0.76
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Business Model Strength
Nutriband's focus on transdermal drug delivery systems offers a unique value proposition in healthcare, enhancing patient compliance and therapeutic outcomes.
Strategic Collaborations
Partnerships with pharmaceutical companies for co-development and licensing agreements expand market access and support revenue growth.
Shareholder Value Enhancement
Issuing Series A Preferred Stock positions Nutriband favorably in the market, potentially increasing shareholder value and financial stability.
Bears Say
Profitability Challenges
Ongoing operational losses and negative cash flows indicate difficulty in achieving profitability, impacting long-term business sustainability.
Negative Cash Flow
Reliance on financing to offset cash deficits is unsustainable, posing risks to financial health if operational improvements are not realized.
Volatile Profit Margins
Inconsistent profit margins highlight challenges in cost management, affecting long-term profitability and competitive positioning.
Nutriband News
9WV FAQ
What was Nutriband’s price range in the past 12 months?
What is Nutriband’s market cap?
When is Nutriband’s upcoming earnings report date?
How were Nutriband’s earnings last quarter?
Is Nutriband overvalued?
Does Nutriband pay dividends?
What is Nutriband’s EPS estimate?
How many shares outstanding does Nutriband have?
What happened to Nutriband’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Nutriband?
What is the TipRanks Smart Score and how is it calculated?
Nutriband Stock Smart Score
Company Description
Nutriband
Nutriband Inc. specializes in developing a diverse range of pharmaceutical products delivered via transdermal patches. The company's most advanced program centers on AVERSA fentanyl, an innovative fentanyl transdermal system engineered to prevent abuse. This extended-release patch provides healthcare professionals and patients with a continuous opioid therapy solution for the ongoing management of chronic pain. Its development pipeline also includes other treatments, such as AVERSA buprenorphine and AVERSA methylphenidate. Additionally, Nutriband is working on exenatide for individuals with type 2 diabetes and follicle stimulating hormone as a treatment for infertility. The company also holds a licensing agreement with Rambam Med-Tech Ltd. to further the development of RAMBAM Closed System Transfer Devices. Nutriband Inc. was founded in 2016 and its main offices are located in Orlando, Florida.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Gareth Sheridan
- Employees
- 13
- Website
- nutriband.com
- Address
- 121 South Orange Avenue, Orlando, FL, 32801, US
Nutriband (9WV) Earnings & Revenues
9WV Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 4 | 10 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 4 | 0 | 8 |
